International Agronomist and Former Monsanto Executive Dr. Ted Crosbie Joins Inocucor Technologies Board of Directors

MONTREAL, March 18, 2015—Inocucor Technologies Inc., the Montreal-based agriculture biotech company that produces sustainable biological products, welcomed internationally recognized agronomist and former Monsanto executive Dr. Ted Crosbie to its Board of Directors today.

“Ted’s recognized scientific intellect and deep connection to agronomy in the lab and in the field will add valuable expertise to Inocucor’s board, as we continue to pioneer and commercialize sustainable biological products for agriculture,” said Inocucor’s President and CEO Donald R. Marvin, a veteran of the North American bioscience industry.

Crosbie currently serves as Chief Technology Officer and Chair of the Iowa Innovation Council for the State of Iowa. He has led agronomic research and development programs for leading U.S. agriculture companies, including Monsanto. He led the formation and managed one the world’s largest plant-breeding programs for a dozen years. Crosbie served in various roles at Monsanto, including VP of Integrated Farming Systems and Director of Global Wheat Breeding, from 1996 until his retirement in 2014.

From 1990 to 1995, he was President and CEO of ICI Seeds (aka Garst Seed), USA, which was acquired by Syngenta, a world-leading agribusiness company focused on crop protection and production of high-value seeds. Crosbie’s early career was spent as a plant breeding graduate faculty member in Iowa State University’s Agronomy Department.

“I was immediately attracted to Inocucor because its microbial consortia technology and strategy are so very different from others in the biologicals space,” said Crosbie. “The company’s data from various field and demonstration trials for row crops and high-value produce convinced me that Inocucor is on the right track in delivering a powerful sustainable solution for today’s farmers.”

Crosbie’s election to the Inocucor Board follows the addition earlier this month of Bayer CropScience CEO Jim Blome as Independent Non-Executive Chairman of Inocucor’s board.

Inocucor produces biological soil, seed and plant accelerators that improve yields, speed maturation and promote healthier, more resilient soils and plants for organic farmers, greenhouse growers and mainstream production farmers. Its first product, Inocucor™Garden Solution®, is sold in Canada and 24 U.S. states and is OMRI Listed® for use in organic production.

Inocucor has co-product development partnerships underway with Axter Agrosciences Inc., one of Canada’s leading providers of foliar feeding crop solutions, and with McGill University’s Department of Plant Sciences.

Leave a Reply

Your email address will not be published.

clear formPost comment


Inocucor Technologies Inc., based in Montreal, is an ag biotech company that develops sustainable biological products for agriculture targeting the phyto-microbiome—the seeds, plants, root systems and the soil surrounding them. Inocucor’s first-generation product, Garden Solution®, soon to be re-branded as Synergro, employs live microbes to actively improve the health of the entire phyto-microbiome. Its second product, Synergro Free and future generations of Inocucor products are powerful biological formulations for bio-stimulation, bio-fertility and bio-control targeting mainstream production agriculture.

For more information, visit